Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of ...

BD (BDX), the MedTech firm also known as Becton, Dickinson, traded lower in the premarket on Monday despite posting better-than-expected financials for Q1 fiscal 2026, as its life sciences segment ...

Becton Dickinson and Company (BD) has trimmed its fiscal year 2026 (FY26) profit outlook to account for the spin-off of its biosciences & diagnostic solutions business, prompting its share price to ...

Amount reflects the estimated impact to adjusted diluted earnings per share for fiscal year 2025 from the proposed disposition of the Bioscience and Diagnostics Solutions business that will be ...

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory ...

The investment seeks to track the investment results of the ICE BofA U.S. High Yield Constrained Index. The fund will invest at least 80% of its assets in the component securities of the underlying ...

BD (NYSE: BDX) + shares dipped before hours today despite first-quarter results that came in ahead of the consensus Wall Street forecast. Shares of BDX 4% to $201.80 apiece in pre-market trading today ...

A minimalist, fast, and offline-first Android utility app for compressing PDF files. Built with Flutter and optimized for Amazon Appstore approval and Google AdMob monetization.